SUMOylation inhibitor TAK-981 suppresses proliferation and induces apoptosis in SK-UT-1B uterine leiomyosarcoma cells
Hosouk Joung, Hyunju Liu · 2026
Read SUMOylation inhibitor TAK-981 suppresses proliferation and induces apoptosis in SK-UT-1B uterine leiomyosarcoma cells by Hosouk Joung, Hyunju Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13329716.txt.
Description
Hosouk Joung and Hyunju Liu test a SUMO-blocking drug on womb muscle cancer cells in a 2026 study. Uterine leiomyosarcoma is fast-growing with few treatment options. The drug TAK-981, also called subasumstat, blocks enzymes that attach SUMO tags to proteins and has shown action in other cancers.
One cell line, SK-UT-1B, proved far more sensitive than SK-UT-1 in the reported tests. The drug cut cell survival in a dose and time linked way, triggered cell death by 48 hours, and halted cells in an early growth phase. It also raised harmful oxygen species and weakened cell power units. Death was partly tied to those species. SUMO tagging fell and death markers rose, while self-eating markers stayed flat.
Catalog record
| CREATOR | Hosouk Joung, Hyunju Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26564 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |